Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (4)
  • Videos (15)
  • Events (2)
  • Startup Opportunities (10)
  • Startups
  • Founders
Please sign-in to see the full search results
36 search results found
  • Asimov, Inc.

    Cambridge, Massachusetts
    Biotechnology
    Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More
    Asimov-color
  • Cracking Cancer 2.0 - Lightning Talks

    Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

  • Stratagen Bio

    Cambridge, MA
    Biotechnology
    Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More
    Keywords:
    Oxygen Sensing, Magnetic Resonance Imaging, Image-Guided Therapies, personalized medicine
    StratagenBio Logo color
  • Vaxess Technologies, Inc.

    Cambridge, MA
    Biotechnology
    Vaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead program is a sustain-release flu microneedle patch. We also have a pipeline of undisclosed targets including mRNA, immun/ooncology and other... More
    Vaxess
  • Cracking Cancer 2.0 - Industry/MIT Moment

    Cracking Cancer 2.0 - Industry/MIT Moment

    December 7, 2017 | Startup Exchange Video | Duration: 2:46

    Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program

  • Past Deadline: Feb 5, 2021

    P&G seeks startups for innovative consumer experience

    other

    P&G is seeking startups for innovative consumer experiences: 1) Making a Sustainable Lifestyle Effortless 2) AI Technologies for Digital Expert Advisors with conversational AI and hybrid human-ML,  3) Transformative Transactions including sourcing, manufacturing, distribution, and autonomous supply chain, 4) Automation of Daily In-Home Consumer Tasks, and 5) Enabling Breakthrough Growth for Omnichannel Brands.

  • Natan Linder, Founder, Tulip

    Tulip

    December 5, 2016 | Startup Exchange Video | Duration: 31:41

    Natan Linder, Founder, Tulip

  • Paula Hammond

    Cracking Cancer 2.0 - Cancer Innovation - The Long View

    December 7, 2017 | Startup Exchange Video | Duration: 15:22

    Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio

  • Ling-Synthetic Biology

    Synthetic Biology Workshop 2017 - Industry View - Why We Care About New Materials

    September 12, 2017 | Startup Exchange Video | Duration: 10:27

    Vincent Ling, Senior Director, Materials and Innovation, Takeda 

  • Cracking Cancer 2.0 - Panel Discussion

    Cracking Cancer 2.0 - Panel Discussion

    December 7, 2017 | Startup Exchange Video | Duration: 47:30

    Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.

Pagination

  • of 4
  • 1
  • 2
  • 3
  • 4
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations